Last edition
News about "In its recent statement Lupin has said that it rec"
US FDA approval: Lupin can now market its generic drugs
In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market
In Its Recent Statement Lupin Has Said That It Rec | 07/03/2022 | By Darshana | 343
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members